• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

八种β-内酰胺类抗生素在腹膜液中的渗透情况。一项药代动力学研究。

Penetration of eight beta-lactam antibiotics into the peritoneal fluid. A pharmacokinetic investigation.

作者信息

Wittman D H, Schassan H H

出版信息

Arch Surg. 1983 Feb;118(2):205-13. doi: 10.1001/archsurg.1983.01390020055010.

DOI:10.1001/archsurg.1983.01390020055010
PMID:6849637
Abstract

Serial serum and peritoneal fluid samples were taken after intravenous injection of cefuroxime sodium, cefoxitin sodium, cefotaxime sodium, cefoperazone sodium, ceftazidime, moxalactam disodium, mezlocillin sodium, and piperacillin sodium. Time-concentration curves were obtained for both pharmacokinetic compartments. The geometric mean of peritoneal fluid concentrations from eight to ten patients was used to define the time-concentrations curve for each substance. Serum pharmacokinetic values were calculated using an open two-compartment model. The concentrations (Cps) were calculated from peritoneal fluid concentrations by quadratic interpolation. The time for which one fourth of the Cp (Cp1/4) is maintained within the peritoneal cavity varied according to the substance and can be used to estimate dosage intervals. The Cp1/4 was compared with the minimal inhibitory concentrations for 1,344 pathogens encountered in 415 intra-abdominal infections from 31 studies.

摘要

静脉注射头孢呋辛钠、头孢西丁钠、头孢噻肟钠、头孢哌酮钠、头孢他啶、拉氧头孢二钠、美洛西林钠和哌拉西林钠后,采集系列血清和腹腔液样本。获得了两个药代动力学房室的时间-浓度曲线。使用八至十名患者腹腔液浓度的几何平均值来确定每种物质的时间-浓度曲线。血清药代动力学值采用开放二房室模型计算。浓度(Cps)通过二次插值法从腹腔液浓度计算得出。腹腔内维持四分之一Cp(Cp1/4)的时间因物质而异,可用于估计给药间隔。将Cp1/4与31项研究中415例腹腔内感染中遇到的1344种病原体的最低抑菌浓度进行比较。

相似文献

1
Penetration of eight beta-lactam antibiotics into the peritoneal fluid. A pharmacokinetic investigation.八种β-内酰胺类抗生素在腹膜液中的渗透情况。一项药代动力学研究。
Arch Surg. 1983 Feb;118(2):205-13. doi: 10.1001/archsurg.1983.01390020055010.
2
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.头孢他啶:与头孢噻肟、拉氧头孢及其他β-内酰胺类抗生素相比的体外抗菌活性及对β-内酰胺酶的敏感性
J Antimicrob Chemother. 1981 Sep;8 Suppl B:23-31. doi: 10.1093/jac/8.suppl_b.23.
3
[Antibiotic concentrations in the abdominal cavity as basis for antibacterial therapy of peritonitis: penetration of mezlocillin into the peritoneal exudate].[腹腔内抗生素浓度作为腹膜炎抗菌治疗的依据:美洛西林在腹膜渗出液中的渗透情况]
Infection. 1982;10 Suppl 3:S204-8. doi: 10.1007/BF01640673.
4
Distribution of moxalactam in serum, bone, tissue fluid, and peritoneal fluid.羟羧氧酰胺菌素在血清、骨骼、组织液和腹水中的分布。
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S610-6. doi: 10.1093/clinids/4.supplement_3.s610.
5
Penetration of prophylactic antibiotics into peritoneal fluid.预防性抗生素在腹膜液中的渗透。
Am J Surg. 1989 Jun;157(6):585-7. doi: 10.1016/0002-9610(89)90707-1.
6
Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study.严重腹腔感染危重症患者大剂量β-内酰胺类药物治疗后血清和腹腔渗出液浓度:一项观察性前瞻性研究。
J Antimicrob Chemother. 2020 Jan 1;75(1):156-161. doi: 10.1093/jac/dkz407.
7
The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
J Antimicrob Chemother. 1981 Sep;8 Suppl B:63-6. doi: 10.1093/jac/8.suppl_b.63.
8
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.头孢他啶(Gr 20263)的体内抗菌活性——与其他新型β-内酰胺类抗生素及庆大霉素的比较
J Antimicrob Chemother. 1981 Sep;8 Suppl B:247-55. doi: 10.1093/jac/8.suppl_b.247.
9
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.与头孢噻肟及其他β-内酰胺类抗生素相比,拉氧头孢(LY-127935)对肠杆菌科和非发酵菌临床分离株的抗菌活性。
Arzneimittelforschung. 1981;31(6):982-6.
10
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
J Antimicrob Chemother. 1982 Jan;9 Suppl A:101-6. doi: 10.1093/jac/9.suppl_a.101.

引用本文的文献

1
Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients.亚洲患者中帕博西尼相关中性粒细胞减少症发生率较高的临床和基因分析。
Oncologist. 2024 Apr 4;29(4):e455-e466. doi: 10.1093/oncolo/oyad304.
2
Operative and nonoperative therapy of intraabdominal infections.腹腔内感染的手术及非手术治疗
Infection. 1998 Sep-Oct;26(5):335-41. doi: 10.1007/BF02962267.
3
Management of secondary peritonitis.继发性腹膜炎的管理
Ann Surg. 1996 Jul;224(1):10-8. doi: 10.1097/00000658-199607000-00003.
4
The efficacy of cefotaxime in gram-positive surgical infections.
Infection. 1985;13 Suppl 1:S37-42. doi: 10.1007/BF01644216.
5
Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis.新型β-内酰胺类药物治疗阑尾炎的随机、前瞻性、双盲试验
Antimicrob Agents Chemother. 1985 Nov;28(5):639-42. doi: 10.1128/AAC.28.5.639.
6
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
7
Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations.静脉注射头孢噻肟与口服新霉素-红霉素用于结直肠手术后感染的预防
World J Surg. 1988 Jun;12(3):369-73. doi: 10.1007/BF01655676.
8
Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage.
World J Surg. 1990 Mar-Apr;14(2):176-83. doi: 10.1007/BF01664870.
9
Etappenlavage: advanced diffuse peritonitis managed by planned multiple laparotomies utilizing zippers, slide fastener, and Velcro analogue for temporary abdominal closure.分期冲洗:通过使用拉链、滑动扣件和类似维可牢尼龙搭扣的装置进行计划性多次剖腹手术来处理进展期弥漫性腹膜炎,以实现腹部的临时闭合。
World J Surg. 1990 Mar-Apr;14(2):218-26. doi: 10.1007/BF01664876.
10
Principles and limitations of operative management of intraabdominal infections.腹腔内感染手术治疗的原则与局限性
World J Surg. 1990 Mar-Apr;14(2):210-7. doi: 10.1007/BF01664875.